Charles Chiedu Nwaokobia
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$9.0MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $9.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 6, 2025 | NIH | SBIR Phase II Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $1.2M | EVON MEDICS LLC |
| Mar 6, 2025 | NIH | SBIR Phase II Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $1.3M | EVON MEDICS LLC |
| Jul 24, 2024 | NIH | SBIR Phase II Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $1.2M | EVON MEDICS LLC |
| Jun 13, 2024 | NIH | SBIR Phase II The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $1.2M | EVON MEDICS LLC |
| Mar 11, 2024 | NIH | SBIR Phase II Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $1.3M | EVON MEDICS LLC |
| Jul 19, 2023 | NIH | SBIR Phase II Development and Evaluation of Portable Compendium of Psychophysical and Physiological Tests for Alzheimer's Disease and Related Dementias (ADRD) | $449K | EVON MEDICS LLC |
| Jun 22, 2023 | NIH | SBIR Phase II The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $1.3M | EVON MEDICS LLC |
| Feb 3, 2023 | NIH | SBIR Phase II The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $55K | EVON MEDICS LLC |
| Sep 19, 2022 | NIH | SBIR Phase II Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P) | $500K | EVON MEDICS LLC |
| Apr 27, 2022 | NIH | SBIR Phase II The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR) | $331K | EVON MEDICS LLC |
Peer ranks
Federal funding#91
Awards as PI#141
Patents#505
Companies
- EVON MEDICS LLCLinked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.